Alcohol Use Disorder Market Report and Forecast 2024-2032

Alcohol Use Disorder Market Overview

Alcohol use disorder (AUD) is a medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. It ranges from mild to severe and can include symptoms like cravings, withdrawal, and a high tolerance for alcohol.

Alcohol Use Disorder Market Growth Drivers

Growing Awareness and Emphasis on Public Health to Boost Market Growth

Rising public awareness about alcohol misuse and increasing health campaigns are key drivers of the alcohol use disorder (AUD) market. For instance, in June 2024, the World Health Organization (WHO) released a global status report on alcohol and substance use disorders, revealing that 2.6 million deaths annually are attributed to alcohol consumption, with men disproportionately affected. This report underscores the urgent need for comprehensive interventions, which is expected to drive the development of effective treatments and strategies. As the spotlight on AUD grows, demand for innovative therapies and services is projected to fuel market growth during the forecast period.

Advent of New Therapies to Meet Rising Alcohol Use Disorder Market Demand

The growing demand for novel therapeutic approaches and the integration of psychological therapies into AUD treatment are driving innovation in the market. For instance, in August 2024, in a landmark phase III trial, the UK’s National Health Service (NHS) will be investigating ketamine-assisted therapy for preventing alcohol relapse, combining low-dose ketamine infusions with psychological support. Covering 280 adults across multiple NHS sites, this trial is aimed at establishing a groundbreaking treatment model. If successful, the introduction of ketamine-assisted therapy could revolutionise AUD treatment, expand therapeutic portfolios, and significantly drive market development by meeting the unmet needs of severe AUD patients during the forecast period.

Alcohol Use Disorder Market Trends

Alcohol Use Disorder Market Segmentation

Alcohol Use Disorder Market Share

Market Segmentation Based on Disorder Type to Witness Growth

The market share is dominated by the alcohol dependence segment, attributed to the higher prevalence of alcohol dependence compared to other types of disorders, such as alcohol abuse or addiction. Alcohol dependence is often characterized by a strong physical desire to consume alcohol, which leads to significant healthcare needs and treatment services. This segment's growth is driven by increasing recognition of alcohol dependence as a medical condition that requires comprehensive treatment strategies, including medication, counseling, and support services, fueling the demand for effective solutions.

Alcohol Use Disorder Market Analysis by Region

The United States leads the regional market share, primarily due to its high prevalence of alcohol use disorder, significant healthcare spending, and robust access to treatment options. The U.S. market benefits from a strong presence of major pharmaceutical companies actively developing treatments, coupled with widespread awareness and a solid healthcare infrastructure supporting early diagnosis and intervention. This region also sees substantial investment in research and development, promoting innovations in therapy and drug development to tackle alcohol dependency effectively.

Leading Players in the Alcohol Use Disorder Market

The key features of the market report comprise clinical trials analysis, patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Alkermes

Alkermes plc is a biopharmaceutical company headquartered in Dublin, Ireland, established in 1987. Alkermes offers Vivitrol, a once-monthly injectable formulation of naltrexone that helps prevent relapse in patients after they have detoxified. This product is part of a broader portfolio focusing on central nervous system disorders.

BioCorRx, Inc.

BioCorRx, Inc. is a U.S.-based healthcare solutions company founded in 2008, headquartered in Anaheim, Califor...

Ethypharm

Ethypharm is a pharmaceutical company headquartered in Saint-Cloud, France, founded in 1977. Ethypharm provide...

INDIVIOR

INDIVIOR is a pharmaceutical company based in Slough, UK, established in 1994. INDIVIOR offers products like S...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Omeros Corporation, Kinnov Therapeutics, and Adial Pharmaceuticals.

Key Questions Answered in the Alcohol Use Disorder Market

• What was the alcohol use disorder market value in 2023?
• What is the alcohol use disorder market forecast outlook for 2024-2032?
• What is the market breakup based on the disorder type?
• What is the market breakup based on the treatment type?
• What is the market breakup based on the end user?
• What are the major factors aiding the alcohol use disorder market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which country is expected to experience expedited growth during the forecast period?
• What are the major alcohol use disorder market trends?
• Which disorder type will lead the market segment?
• Which treatment type will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the alcohol use disorder market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?